US Patent Issued to VIB VZW, UNIVERSITEIT GENT, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, UNIVERSITE DE MONTPELLIER, CENTRE HOSPITALIER REGIONAL UNIVERSITAIRE DE MONTPELLIER on Sept. 22 for "Targeting of human interferon antagonists" (Belgian, French Inventors)

ALEXANDRIA, Va., Sept. 24 -- United States Patent no. 12,741,998, issued on Sept. 22, was assigned to VIB VZW (Ghent, Belgium), UNIVERSITEIT GENT (Ghent, Belgium), CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (Paris), UNIVERSITE DE MONTPELLIER (Montpellier, France) and CENTRE HOSPITALIER REGIONAL UNIVERSITAIRE DE MONTPELLIER (Montpellier, France).

"Targeting of human interferon antagonists" was invented by Jan Tavernier (Balegem, Belgium), Lennart Zabeau (Ghent, Belgium), Gilles Uze (Montpellier, France), Franciane Paul (Montpellier, France), Yann Bordat (Montpellier, France) and Genevieve Garcin (Montpellier, France).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a fusion pro...